Seriously, I can't wait for the PD1-Vaxx announcement. I feel it will give a true indication of how potent the B-cell tech is. Especially this trial is being done on patients who are all on the highway to heaven. And the fact that it is a monotherapy, there can be no doubt about the efficacy of the PD1-Vaxx whatever the result is. Hopefully, more patients with CRs on the way. That will bring lots of Christmas joy to both the patients and the shareholders
IMU Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)